Contact Dermatitis - Pipeline Review, H2 2017

Publisher Name :
Date: 12-Sep-2017
No. of pages: 52
Inquire Before Buying

Contact Dermatitis - Pipeline Review, H2 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Contact Dermatitis - Pipeline Review, H2 2017, provides an overview of the Contact Dermatitis (Dermatology) pipeline landscape.

Contact dermatitis is a type of skin inflammation that occurs when substances touching skin cause irritation or an allergic reaction. Signs and symptoms of contact dermatitis include red rash or bumps, dry, cracked, red patches, which may resemble a burn and pain or tenderness. There are two types of contact dermatitis; irritant and allergic. Irritant dermatitis, the most common type, is caused by contact with acids, alkaline materials such as soaps and detergents, fabric softeners, solvents, or other chemicals. The reaction usually looks like a burn. Allergic contact dermatitis is an itchy skin condition caused by an allergic reaction to allergen. Treatment includes oral corticosteroids and antihistamines to relieve intense itching.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Contact Dermatitis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Contact Dermatitis (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Contact Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 3, 3 and 6 respectively.

Contact Dermatitis (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Contact Dermatitis (Dermatology).

- The pipeline guide reviews pipeline therapeutics for Contact Dermatitis (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Contact Dermatitis (Dermatology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Contact Dermatitis (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Contact Dermatitis (Dermatology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Contact Dermatitis (Dermatology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Contact Dermatitis (Dermatology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Contact Dermatitis - Pipeline Review, H2 2017

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Contact Dermatitis - Overview
Contact Dermatitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Contact Dermatitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Contact Dermatitis - Companies Involved in Therapeutics Development
Brickell Biotech Inc
Dr. August Wolff GmbH & Co KG Arzneimittle
NeuroCycle Therapeutics GmbH
Novartis AG
Pfizer Inc
RaQualia Pharma Inc
Contact Dermatitis - Drug Profiles
AAT-008 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AN-3485 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BBI-2000 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EB-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EB-05 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
grapiprant - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HPT-721 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NCT-10004 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pertussis [strain BPZE1] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
secukinumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SIG-1322 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
WOL-071007 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Contact Dermatitis - Dormant Projects
Contact Dermatitis - Discontinued Products
Contact Dermatitis - Product Development Milestones
Featured News & Press Releases
Nov 19, 2015: Hapten Sciences to Begin Clinical Trials for Novel Poison Ivy Vaccine
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Contact Dermatitis, H2 2017
Number of Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Contact Dermatitis - Pipeline by Brickell Biotech Inc, H2 2017
Contact Dermatitis - Pipeline by Dr. August Wolff GmbH & Co KG Arzneimittle, H2 2017
Contact Dermatitis - Pipeline by NeuroCycle Therapeutics GmbH, H2 2017
Contact Dermatitis - Pipeline by Novartis AG, H2 2017
Contact Dermatitis - Pipeline by Pfizer Inc, H2 2017
Contact Dermatitis - Pipeline by RaQualia Pharma Inc, H2 2017
Contact Dermatitis - Dormant Projects, H2 2017
Contact Dermatitis - Discontinued Products, H2 2017

List of Figures
Number of Products under Development for Contact Dermatitis, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Targets, H2 2017
Number of Products by Stage and Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017
  • United States Pressure Ulcer Treatment Products Market Report 2017
    Published: 22-Nov-2017        Price: US 3800 Onwards        Pages: 103
    In this report, the United States Pressure Ulcer Treatment Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share a......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Botox Market 2017 Forecast to 2022
    Published: 21-Nov-2017        Price: US 4880 Onwards        Pages: 121
    Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage. Scope of the Report: This report focuses on the Botox in Global ma......
  • Global Dermal Fillers Sales Market Report 2017
    Published: 21-Nov-2017        Price: US 4000 Onwards        Pages: 106
    In this report, the global Dermal Fillers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Dermal Fillers for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - ......
  • Global Pressure Ulcer Treatment Products Sales Market Report 2017
    Published: 17-Nov-2017        Price: US 4000 Onwards        Pages: 106
    In this report, the global Pressure Ulcer Treatment Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Pressure Ulcer Treatment Products for these regions, from 2012 to 2022 (forecast), covering - United States - China......
  • United States Dermal Fillers Market Report 2017
    Published: 15-Nov-2017        Price: US 3800 Onwards        Pages: 103
    In this report, the United States Dermal Fillers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of D......
  • Global and China Hyaluronic Acid Based Dermal Fillers Market Research by Company, Type & Application 2013-2025
    Published: 15-Nov-2017        Price: US 2000 Onwards        Pages: 106
    Summary Market Segment as follows: By Type - Single-phase product - Duplex product By Application - Bootlegging - Sculpting - Fill Scars - Others By Company - Galderma - Allergan - Sanofi - Merz - LG Life Sciences - Sinclair - Teoxane - Anika Therapeutics - Hyaltech - Mentor - Adoderm - SciVision Biotech -......
  • Impetigo - Pipeline Review, H2 2017
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 41
    Impetigo - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Pipeline Review, H2 2017, provides an overview of the Impetigo (Infectious Disease) pipeline landscape. Impetigo is a highly contagious skin condition. Impetigo is caused by two bacteria streptococcus pyogenes and staphylococcus aureus. Symptoms include fluid-filled blisters, itchy rash, skin lesions and swollen lymp......
  • Systemic Lupus Erythematosus - Pipeline Review, H2 2017
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 427
    Systemic Lupus Erythematosus - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus - Pipeline Review, H2 2017, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape. Systemic lupus erythematosus (SLE) is an autoimmune disease that causes a chronic inflammatory condition. The inflammation triggered by SLE affect many organs in ......
  • Pemphigus Vulgaris - Pipeline Review, H2 2017
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 54
    Pemphigus Vulgaris - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pemphigus Vulgaris - Pipeline Review, H2 2017, provides an overview of the Pemphigus Vulgaris (Immunology) pipeline landscape. Pemphigus vulgaris is a rare autoimmune disease that causes painful blistering on the skin and the mucous membranes. Risk factors include race, gender and age. Symptoms of pemphigus vulgaris i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs